Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFeeling really sick on Mounjaro is one of the most common reasons people contact their prescriber in the first few weeks of treatment. Nausea affects a significant proportion of users, particularly around dose increases, but it usually settles. Here's what the clinical evidence says about why it happens, how long it tends to last, and when to act — so you can make a more informed decision about what comes next. Mounjaro (tirzepatide) is a prescription-only medicine; a GPhC-registered prescriber assesses suitability before any treatment begins, and any concerning symptoms should always be discussed with a clinician.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide works partly by slowing gastric emptying, the speed at which food travels from the stomach into the small intestine. That slowdown is useful for appetite regulation, but it also means food and stomach acid sit together longer than your body is used to. The result, for many people, is a persistent queasy feeling that can range from mild unease to active vomiting. The full side-effect profile of Mounjaro includes nausea, vomiting, diarrhoea, constipation, indigestion, burping and fatigue, all linked to this GI mechanism. None of them reflect an allergic reaction or a sign the medicine is harming you in a serious way; they are, frustratingly, the same pathway that makes the treatment effective.
The NHS tirzepatide medicines page confirms that gastrointestinal effects are among the most commonly reported, and the clinical trials that led to Mounjaro's UK licence showed these side effects were most pronounced early in treatment and at dose-increase points. That timing matters, because it tells you something practical: if you've just moved from one pen strength to the next and you're feeling much worse, the sickness is almost certainly a response to the new dose, not a sign something has gone seriously wrong.
One quick check worth doing before each injection: look at when you last ate and what you had. Fatty, rich or large meals right before or after dosing consistently make GI side effects worse. Keeping a brief mental note of that pattern takes under a minute and can help you identify a fixable trigger.
For most people, the worst nausea at each dose level settles within one to two weeks. The body adapts to the new pace of gastric emptying, and the signals that were firing loudly start to quieten. This pattern repeats at each dose increase, which is why the titration schedule exists: moving through doses gradually gives the gut time to recalibrate rather than jumping straight to a maintenance dose. If you're curious about what mild to moderate nausea on Mounjaro looks like across the broader population, the experience varies considerably between individuals.
What should concern you is nausea or vomiting that doesn't follow this pattern, symptoms that stay severe beyond two weeks at a stable dose, or that stop you keeping any fluid down. Persistent vomiting creates a real risk of dehydration, which can affect kidney function. That's a reason to speak to a clinician, not to wait it out. The NHS guidance on tirzepatide is clear that some people may need a dose pause or reduction if side effects become unmanageable, and a prescriber can make that call.
It's also worth noting that if you're feeling exhausted alongside the nausea, that's not unusual. Fatigue alongside nausea on Mounjaro often reflects both the GI disruption and reduced calorie intake as appetite falls, another reason protein intake and hydration deserve particular attention during the adjustment period.
Most nausea on Mounjaro is uncomfortable rather than dangerous. But there are specific symptoms that require prompt medical attention rather than self-management. In January 2026, the MHRA issued a Drug Safety Update for GLP-1 medicines (including tirzepatide) highlighting acute pancreatitis as an infrequent but serious risk. The symptom to recognise is severe, persistent stomach pain that radiates towards the back, which may or may not come with vomiting. This is different from ordinary Mounjaro nausea; it doesn't fluctuate in the same way and tends to be significantly more intense. If that describes what you're feeling, seek urgent medical help.
Other situations that warrant a call to a clinician rather than waiting: you cannot keep fluids down for more than 24 hours; you have signs of dehydration (dizziness on standing, very dark urine, no urination for many hours); or you develop symptoms that don't fit the usual GI picture at all, sudden severe pain, fever, or anything that feels qualitatively different from ordinary nausea. You can read more about what symptoms to watch for after each Mounjaro injection and how timing relates to what you're experiencing. Suspected side effects can also be reported directly to the MHRA via the Yellow Card scheme.
The changes that tend to make the most consistent difference are practical and straightforward. Smaller, lower-fat meals reduce the workload on a stomach that is already emptying slowly, a large, oily meal is the worst combination. Eating more slowly, stopping before you feel full, and sitting or standing upright for at least an hour after eating all help. Cold or room-temperature food is often better tolerated than hot food, which can intensify nausea. Staying well hydrated between meals matters, but drinking large amounts with food can make things worse. Ginger in any form (tea, biscuits, sweets) has modest clinical backing for nausea and is reasonable to try.
If the sickness is severe enough to affect daily life, that is a clinical conversation, not a willpower question. There are structured approaches to managing Mounjaro nausea that a prescriber can discuss with you, including whether a temporary dose hold is appropriate. Some people find the pattern of nausea on tirzepatide shifts considerably once they move past the first dose increase. And if you want to understand how side effects vary by dose specifically, the 5mg dose side-effect experience is worth reviewing if that's where you currently are. A prescriber can review your situation and, if appropriate, adjust the pace of your titration. At the end of this page you'll find a link to start a free consultation with our prescribers, that's the right route if nausea is becoming a barrier to continuing.
For a broader picture of Mounjaro as a treatment, our Mounjaro overview covers eligibility, how the medicine works and what to expect. And if you're still weighing up whether to start, our treatment page outlines all the options our prescribers can discuss with you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.